Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Schwartz, Norman M. (Yale University, New Haven,
Conn
.). Suppression of a lac o degrees mutation in Escherichia coli. J. Bacteriol. 88:996-1001. 1964.-A class of pro(-) markers which can be cotransduced with lac map close to the i side of the lac region. The relative order of markers transferred by Hfr H is thr leu proA proB lac proC ade. Nine of ten slowgrowing lactose-utilizing revertants of a lac o degrees mutant are suppressed mutants. The time of entry of su-lac o-5 from an Hfr H derivative is 27 min. Su-lac o-5 is separated from the lac region by a 10-min interval. Su-lac o-5 is unstable, restores 7% of the wild-type level of
beta-galactosidase
activity, suppresses a try(-) mutation, and has a deleterious effect upon growth rate. The primary lac o degrees mutation is interpreted as being a z(-) polarity mutation which constitutes nonsense. Su-lac o-5 could act at the level of messenger ribonucleic acid translation converting nonsense to sense by promoting mistakes in protein synthesis.
...
PMID:SUPPRESSION OF A LAC O-O MUTATION IN ESCHERICHIA COLI. 1421 65